Inspire Medical Systems, Inc. Announces the Addition of Paul T. Hoff, M.D.

Core Viewpoint - Inspire Medical Systems, Inc. has announced the appointment of two prominent physicians, Dr. Paul T. Hoff and Dr. Ruchir P. Patel, to key leadership roles, aiming to enhance the company's efforts in treating obstructive sleep apnea (OSA) through innovative medical solutions [1][2]. Group 1: Company Overview - Inspire Medical Systems focuses on developing and commercializing minimally invasive solutions for patients with obstructive sleep apnea [1][9]. - The company's proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology for moderate to severe obstructive sleep apnea [9]. Group 2: New Appointments - Dr. Paul T. Hoff will join Inspire as Vice President, Senior Medical Director, effective April 21, 2025, while Dr. Ruchir P. Patel will assume his role on June 2, 2025 [1][2]. - Both physicians are recognized experts in sleep medicine and surgery, with extensive experience in treating sleep apnea patients and familiarity with Inspire therapy [2][8]. Group 3: Dr. Paul T. Hoff's Background - Dr. Hoff holds an M.D. from the University of Michigan Medical School and has over 25 years of clinical practice experience [3][4]. - He has held leadership positions in various organizations, including President of the Michigan Otolaryngology Society and the International Surgical Sleep Society [4]. Group 4: Dr. Ruchir P. Patel's Background - Dr. Patel earned his M.D. from the Royal College of Surgeons in Ireland and has over 15 years of clinical practice experience [6][7]. - He founded The Insomnia and Sleep Institute of Arizona and has been involved in multiple clinical trials and research in sleep medicine [7][8].